More than 130 suppliers

In-house tech support

Call +31 (0)26 326 44 50

Bio-Connect

Products
Products
Antibodies
Chemicals
Proteins / Signaling Molecules
Assays
DNA / RNA / Vectors
Cell Culture
Genome Editing and Engineering
Molecular Biology
Lysates / Extracts
Expression
Labware / Accesories
Body Products
Technique Specific Products
Arrays / Slides
Promotions
All product groups
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
Suppliers
Industries
Industries
Biotech, Pharma & CRO
Academia
Diagnostics
Environment
Food
Veterinary
All industries
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
News

Website
Tech support
About us
About us
Our company
Our team
Divisions
Vacatures
Events
Promotions
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
FAQ
Contact

ProductsBack/ELISA Pro: Human apoA1

ELISA Pro: Human apoA1

ELISA Pro: Human apoA1

Research Use Only

3710-1HP

ReactivityHuman, Primate

Product group Assays

Overview

Supplier
Mabtech
Product Name
ELISA Pro: Human apoA1
Delivery Days Customer
9
Applications
ELISA
Assay Detection Range
0.63-40 ng/ml
Assay Specificity
This kit is based on a matched pair of mAbs specific for human apoA1.
Certification
Research Use Only
Reactivity
Human, Primate
UNSPSC
41116133

References

Bissig-Choisat, B., et al. (2015). Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nature Communications.
Read more
Wang, Y., et al. (2011). Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL. Diabetes care.
Read more
Apro, J., et al. (2015). Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients. Journal of lipid research.
Read more